<DOC>
	<DOCNO>NCT01710930</DOCNO>
	<brief_summary>The main objective study determine double serum TARC ( compare baseline ) associate occurrence exacerbation ABPA . The secondary objective study : 1 . To investigate induced sputum eosinophil count ( compare baseline ) associate occurrence exacerbation . 2 . To examine exhale NO ( compare baseline ) associate occurrence exacerbation . 3 . To investigate activation circulate T cell ( compare baseline ) associate occurrence exacerbation . 4 . To examine rate specific Asp f IgG measure ELISA ( compare baseline ) associate occurrence exacerbation . 5 . To determine variation one marker , TARC Asp f specific IgE measure baseline , may associate radiological stage disease ( ABPA-S , ABPA-CB , ABPA-ORF ) . 6 . To investigate link fungal exposure home ( visually assess contamination level proportion positive sample Asp . f ) frequency exacerbation . 7 . To establish clinical , functional biological data study associated frequency exacerbation .</brief_summary>
	<brief_title>Protocol TARC-ABPA</brief_title>
	<detailed_description />
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Pulmonary Aspergillosis</mesh_term>
	<mesh_term>Aspergillosis , Allergic Bronchopulmonary</mesh_term>
	<criteria>Preinclusion criterion : Major patient , indifferent sex , Patients insure , Patients accept give , information , sign informed consent form , Patients affect ABPA , Patients remission without treatment , stable current treatment least 3 month . Inclusion criterion : This inclusion definitive V1 , : The preinclusion criterion respect , The patient present exacerbation since V0 thereby define basic state . If patient could include , possible rescreen study , provide meet preinclusion inclusion criterion . In case , new V0 schedule least 3 month first V0 . Exclusion criterion : Minor patient , Adults guardianship , Pregnant lactate woman , Patients unable follow protocol give consent , Patients infection lower respiratory tract 4 week precede V0 V0 V1 , Patients hospitalize respiratory problem 4 week precede V0 V0 V1 , Patients chronic inflammatory disease unrelated ABPA could influence result , Patients cancer , Patients follow cystic fibrosis define positive sweat test , Patients know compliance problem identify prior study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Allergic Broncho-Pulmonary Aspergillosis</keyword>
</DOC>